It is supplied for scientific research and laboratory use only
Brett Brechner, DO, offers medically supervised GHK-Cu therapy as a subcutaneous injection or an oral capsule
1 x 2mL vial BPC-157 + TB-500 blend (choose 5mg/5mg or 15mg/15mg)
Proper storage and disposal not only ensure the medications effectiveness but also safety for those in the household
Reconstituting a full 30mL vial provides convenience but subjects the entire volume to 28 days of oxidative exposure even under perfect refrigeration, the final doses in week four have lost 1015% potency compared to week one
This involves the selective degradation of anti-ferroptosis proteins or organelles, such as lipid droplets, GPX4, ferritin, SLC40A1, CDH2, and BMAL1 [105, 106, 175,176,177,178,179,180]